Morphine, but not ketamine, decreases the ratio of Th1/Th2 in CD4-positive cells through T-bet and GATA3

Inflammation

Volumn 35, Issue 3, 2012, Pages 1069-1077

  Gao, Mei ^a   Sun, Jie ^a   Jin, Wenjie ^a   Qian, Yanning ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

GATA3; Ketamine; Morphine; T help cell; T bet

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; IONOMYCIN; KETAMINE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL COUNT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; MALE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; TH1 CELL; TH1 TH2 BALANCE; TH2 CELL;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; GATA3 TRANSCRIPTION FACTOR; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-4; IONOMYCIN; KETAMINE; LYMPHOCYTE ACTIVATION; MALE; MORPHINE; NALOXONE; T-BOX DOMAIN PROTEINS; TETRADECANOYLPHORBOL ACETATE; TH1 CELLS; TH1-TH2 BALANCE; TH2 CELLS; YOUNG ADULT;

EID: 84863793070     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9413-6     Document Type: Article

References (25)

1. Kennedy, R., and E. Celis. 2008. Multiple roles for CD4 positive T cells in anti-tumor immune responses. Immunological Reviews 222: 129-144. (Pubitemid 351430378)
2. Knutson, K.L., and M.L. Disis. 2005. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunological Immunotherapy 54: 721-728. (Pubitemid 40977140)
3. De Monte, L., M. Reni, E. Tassi, et al. 2011. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. The Journal of Experimental Medicine 208: 469-478.
4. Tosolini, M., A. Kirilovsky, B. Mlecnik, et al. 2011. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Research 71: 1263-1271.
5. Ubukata, H., G. Motohashi, T. Tabuchi, et al. 2010. Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. Journal of Surgical Oncology 102: 742-747.
6. Hong, S., J. Qian, J. Yang, H. Li, L.W. Kwak, and Q. Yi. 2008. Roles of idiotype-specific t cells in myeloma cell growth and survival: Th1 and CTL cells are tumoricidal while Th2 cells promote tumor growth. Cancer Research 68: 8456-8464.
7. van Sandick, J.W., M.A. Boermeester, S.S. Gisbertz, I.J. ten Berge, T.A. Out, T.C. van der Pouw Kraan, and J.J. van Lanschot. 2003. Lymphocyte subsets and T(h)1/T(h)2 immune responses in patientswith adenocarcinoma of the oesophagus or oesophagogastric junction: Relation to pTNM stage and clinical outcome. Cancer Immunological Immunotherapy 52: 617-624. (Pubitemid 37268194)
8. O'Garra, A., and N. Arai. 2000. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends in Cellular Biology 10: 542-50.
9. Zheng, W., and R.A. Flavell. 1997. Transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene in CD4+T cells. Cell 89: 587-96. (Pubitemid 27511769)
10. Ji, N., R.A. Sosa, and T.G. Forsthuber. 2011. More than just a Tbox: The role of T-bet as a possible biomarker and therapeutic target in autoimmune diseases. Immunotherapy 3: 435-441.
11. Chazan, S., I. Buda, N. Nesher, et al. 2010. Low-dose ketaminer via intravenous patient-controlled analgesia device after vaious transthoracic procedures improves analgesia and patient and family satisfaction. Pain Management Nursing 11: 169-176.
12. Jackson, K., M. Ashby, D. Howell, et al. 2010. The effectiveness and adverse effects profile of "burst" ketamine in refractory cancer pain: The VCOG PM 1-00 study. Journal of Palliative Care 26: 176-83.
13. Gao M, Jin W, Qian Y, Ji L, Feng G, Sun J. Effect of N-methyl-D-aspartate receptor antagonist on T helper cell differentiation induced by phorbol-myristate-acetate and ionomycin. Cytokine 2011 Jul 25.
14. Sacerdote, P., L. Gaspani, and A.E. Panerai. 2000. The opioids antagonist naloxone induces a shift from type 2 to type 1 cytokine pattern in normal and shin-grafted mice. Annals of the New York Academy of Sciences 917: 755-763.
15. Domino, E.F., E.K. Zsigmond, L.E. Domino, et al. 1982. Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmento-graphic assay. Anesthesia and Analgesia 61: 87-92. (Pubitemid 12184628)
16. Xie, H., X. Wang, G. Liu, and G. Wang. 2003. Analgesic effects and pharmacokinetics of a low dose of ketamine preoperatively administered epidurally or intravenously. The Clinical Journal of Pain 19(5): 317-322. (Pubitemid 37075673)
17. Clements, J.A., W.S. Nimmo, and I.S. Grant. 1982. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. Journal of Pharmalogical Sciences 71(5): 539-542. (Pubitemid 12063731)
18. Hammoud, H.A., G. Aymard, P. Lechat, N. Boccheciampe, B. Riou, and F. Aubrun. 2011. Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine- 6-glucuronide, and intravenous morphine titration outcomes in the postoperative period. Fundamental and Clinical Pharmacology 25 (4): 518-527.
19. Greeneltch, K.M., A.E. Kelly-Welch, Y. Shi, and A.D. Keegan. 2005. Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism. Journal of Immunology 175(8): 4999-5005. (Pubitemid 41456382)
20. Kirchmayer U, Davoli M, Verster A. Naltrexone maintenance treatment for opioid dependence. Cochrane Database System Review 2003; 2:CD001333.
21. Giacomelli, R., P. Cipriani, M. Matucci Cerinic, A. Fulminis, G. Barattelli, E. Pingiotti, M. Di Franco, A. Trotta, R. Perricone, F. Zazzeroni, E. Alesse, and G. Tonietti. 2002. Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNFalpha production without decreasing TNFalpha mRNA levels. An in vivo and in vitro study. Clinical and Experimental Rheumatology 20(3): 365-372. (Pubitemid 35012571)
22. Hackstein, H., J. Misterek, A. Nockher, A. Reiter, G. Bein, and W. Woessmann. 2009. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications. Transfusion 49(11): 2366-2373.
23. Okuno, K., K. Taya, C.R. Marmarou, P. Ozisik, G. Fazzina, A. Kleindienst, S. Gulsen, and A. Marmarou. 2008. The modulationof aquaporin-4 by using PKC-activator (phorbol myristate acetate) and V1a receptor antagonist (SR49059) following middle cerebral artery occlusion/reperfusion in the rat. Acta Neurochirurgia Suppl. 102: 431-436.
24. Liu, Q.G., D.L. Yang, Y. Huang, E.L. Jiang, S.Y. Zhou, Y. He, Z. D. Wang, M. Wang, Z. Zhou, W.J. Zai, S.Z. Feng, and M.Z. Han. 2006. Influence of G-CSF mobilization on functions of donor T lymphocyte subpopulation and acute graft-versus-host disease. Zhongguo Shi Yan Xue Ye Xue Za Zhi 14(1): 107-111.
25. Braun, S., N. Gaza, R. Werdehausen, H. Hermanns, I. Bauer, M.E. Durieux, M.W. Hollmann, and M.F. Stevens. 2010. Ketamine induces apoptosis via the mitochondrial pathway in human lymphocytes and neuronal cells. British Journal of Anaesthesia 105: 347-354.